Efficacy Studies

Efficacy study is a key step in the development of new disease treatments. Most frequently, a compound will only be tested in patients once it has been shown to be efficacious in preclinic. At Voxcan, in order to evaluate the efficacy of new therapeutics as compared to existing reference treatments, we characterize and develop animal models that reliably reflect the human disease. Our goal is to identify a limited number of animal models based on a positive control group and a test group to monitor the response to your new therapeutic molecules.

In addition Voxcan’s technical platform enables to consolidate your readouts using a wide range of high technologies, thereby ensuring accurate measurements, improving the comparability of the preclinical work and accelerating the development of your new drugs into the clinic, and at a high quality context.